Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00541307 · ClinicalTrials.gov registry record · NA
GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of SFA Obstructive Disease (VIPER)
A NA study of Peripheral Vascular Diseases, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
- 5
- Study locations
NCT00541307 is a NA study of Peripheral Vascular Diseases that has completed, run by W.L.Gore & Associates. The registered enrollment target is 119 participants, below the 490-participant average among 19 other Peripheral Vascular Diseases trials with a reported enrollment target (76% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT00541307, a NA study of Peripheral Vascular Diseases, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objective of the study is collect data on the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface in the treatment of chronic Superficial Femoral Artery disease. Device patency at 12 months is the primary endpoint.
Conditions Studied
Interventions
- DEVICE Treatment with the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface
Study Locations (5)
California
- Tri-City Medical Center - Oceanside
Illinois
- Mercy Hospital and Medical Center - Chicago
Missouri
- Columbia Surgical Associates - Columbia
Texas
- Baylor University Medical Center - Dallas
Wisconsin
- St. Luke's Medical Center - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00541307
The ClinicalTrials.gov registry entry for NCT00541307 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 490-participant average among 19 other Peripheral Vascular Diseases trials with a reported enrollment target (76% lower). The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Vascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Treatment with the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface is the first listed.
NCT00541307 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Illinois, Missouri.
Frequently Asked Questions
What is clinical trial NCT00541307 about?
NCT00541307 is a clinical study titled "GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of SFA Obstructive Disease (VIPER)". The objective of the study is collect data on the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface in the treatment of chronic Superficial Femoral Artery disease. Device patency at 12 months is the primary endpoint.
What is the current status of trial NCT00541307?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2007-10. Estimated completion is 2011-06.
What conditions does trial NCT00541307 study?
This clinical trial studies the following conditions: Peripheral Vascular Diseases.
What interventions are being tested in trial NCT00541307?
The interventions under investigation include: Treatment with the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface (DEVICE).
Who is sponsoring clinical trial NCT00541307?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00541307 being conducted?
This trial has 5 study locations across California, Illinois, Missouri, Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Vascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
RECRUITING · NA
-
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 2
RECRUITING · NA
-
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 3
RECRUITING · NA
-
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
RECRUITING · NA
-
GORE-TEX PROPATEN Vascular Graft Study
COMPLETED · NA
-
Implementation of Telemedicine for Patient With Lower Extremity Wounds
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.